Effects of Malaria in Pregnancy (MiP) on Pregnancy Development and its Outcome: a Critical Review Joshua Djabanor, Elvis Quansah, Du-Bois Asante187_pdf.pdf008-016Malaria, Pregnancy, Placental malaria, VAR2CSA, Placental pathology.90106Malaria is the most important tropical parasitic infection in humans all over the world, and very common in developing countries especially in the tropical zones. The protozoan parasites Plasmodium falciparum, P. vivax, P. malariae and P. ovaleare transmitted through the bite of sporozoite-infected female Anopheles mosquitoes to cause malaria in humans. Malaria in pregnancy (MiP) is a clinical situation in which a pregnant woman is infected with Plasmodium parasite resulting in malaria. MiP is detrimental to both the pregnant woman and her fetus, and it remains as one of the major causes of infant mortality in malaria endemic regions especially in Sub-Saharan Africa. It causes several histopathological changes within the placenta and umbilical cord which manifest in several clinical symptoms. It is one of the key contributors to preterm delivery, low birth weight, intrauterine growth retardation (IUGR), miscarriage, intrauterine death, poor neurodevelopment and immunosuppression in infants. Most distinct systemic proinflammatory responses in pregnancy are characteristics of severe malaria, and excessive activation of the immune system is central to the pathophysiology of placental malaria. There is extensive research on VAR2CSA and its contribution to placental sequestration. Currently, VAR2CSA protein is being made into pregnancy malaria specific vaccines for non-immune mothers to reduce placental malaria infection. This review summarizes the evidences, currently known clinically significant manifestations and the ultimate effect of MiP on pregnancy development. Djabanor J, Quansah E and Asante DB. Effects of Malaria in Pregnancy (MiP) on Pregnancy Development and its Outcome; a Critical Review. J App Biol Biotech. 2017; 5 (02): 008-016. DOI: 10.7324/JABB.2017.502021. Sha'a KK, Oguche S, Watila IM, Ikpa TF. In vitro antimalarial activity of the extracts of Vernonia amygdalina commonly used in traditional medicine in Nigeria. Science World Journal, 2011; 6(2):5-9. 2. World Health Organization: World Malaria Report. Switzerland, 2015; 1-2.www.who.int/malaria/ 3. Ndam NT, Denoeud-Ndam L, Doritchamou J, Viwami F, Salanti A, Nielsen M.A, et al. Protective antibodies against placental malaria and poor outcomes during pregnancy, Benin. Emerging Infectious Diseases. 2015; 21(5):http://dx.doi.org/10.3201/eid2015 4. Samak AC. Malaria in pregnancy: an overview. McGill Journal of Medicine. 2004; 8: 66-71.5. Chen C. Development of antimalarial drugs and their application in China: a historical review. BioMed Central Ltd, 2014; http://www.idpjournal.com/content/3/1/9.6. Walther B, Miles DJC, Waight P, Palmero SM, Ojuola O, Touray ES, et al. Placental malaria is associated with attenuated CD4 T-cell responses to tuberculin PPD 12 months after BCG vaccination. BMC infectious diseases. 2012; 12(6): 1-7. 7. Autino B, Corbett Y, Castelli F, Taramelli D. Pathogenesis of Malaria in Tissues and Blood. Mediterranean Journal of Hematology and Infectious Disease. 2012; 4(1):1-12. 8. Wahlgren M, Treutiger CJ, Gysin J. Cytoadherence and rosetting in pathogenesis of severe malaria: Malaria molecular and clinical aspects. The Netherlands: Harwood Academic Publishers. 1999; pp 289-328. 9. Schofield L, Grau GE. Immunological processes in malaria pathogenesis. Nature Reviews Immunology. 2005; 5(9): 722-735. 10. Dondorp AMC. Direct In Vivo Assessment of Microcirculatory Dysfunction in Severe Falciparum Malaria. Journal of Infectious Diseases. 2008; 197(1): 79-84. 11. Jayakumar PS, Demba S, Geoffrey S, Tamas S, Moore JM. Malaria-Induced Murine Pregnancy Failure: Distinct Roles for IFN- γ and TNF. Journal of Immunology. 2009; 183(8):5342-5349. 12. David PH, Hommel M, Miller LH, Udeinya IJ, Oligino LD. Parasite sequestration in Plasmodium falciparum malaria: spleen and antibody modulation of cytoadherence of infected erythrocytes. Proceedings of the National Academy of Sciences U.S.A. 1983; 80(16): 5075-5079. 13. Costa FTM, Avril M. Cytoadhesion of Plasmodium falciparum-infected erythrocytes and the infected placenta: a two-way pathway. Brazilian Journal of Medical and Biological Research. 2006; 39(12): 1525-1536. 14. Guyatt HL and Snow R.W. Malaria in pregnancy as an indirect cause of infant mortality in sub-Saharan Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2001; 95(6):569-576. 15. Desai MO, Kuile F, Nosten F, McGready R, Asamoa K, Brabin B, et al. Epidemiology and burden of malaria in pregnancy. Infectious Disease. 2007; 7(2):93-104. 16. Falade CO, Tongo OO, Ogunkunle OO, Orimadegun AE. Effects of malaria in pregnancy on newborn anthropometry. The Journal of Infection in Developing Countries. 2010; 4(7):448-453. 17. Raimi OG &Kanu CP. The prevalence of malaria infection in pregnant women living in a suburb of Lagos, Nigeria.African Journal of Biochemistry Research.2010; 4(10): 243-245.18. Gunn JKL, Ehiri JE, Jacobs ET, Ernst KE, Pettygrove S, Kohler LN et al. Population-based prevalence of malaria among pregnant women in Enugu State, Nigeria: the Healthy Beginning Initiative.Malaria Journal. 2015;14(438):DOI 10.1186/s12936-015-0975-x 19. Eijk AMV, Noor AM, Snow RW, Kuile FO. Prevalence of malaria infection in pregnant women compared with children for tracking malaria transmission in sub-Saharan Africa: a systematic review and meta-analysis. The Lancet Journals. 2015; 3(10):DOI: http://dx.doi.org/10.1016/S2214-109X(15)00049-2.20. President's Malaria Initiative Report; Ghana Malaria Operational Plan FY 2015. www.pmi.gov/where-we-work/ghana21. Rovira-Vallbona E, Monteiro I, Bardajı´ A, Serra-Casas E, Neafsey DE, Quelhas D. et al. VAR2CSA Signatures of High Plasmodium falciparum Parasitaemia in the Placenta.PLoS ONE. 2013; 8(7): e69753. doi:10.1371/journal.pone.006975322. Rogerson SJ, Brown HC, Cooke BM, Brown GV. Placental tumor necrosis factor alpha but not gamma interferon is associated with placental malaria and low birth weight in Malawian women. Infection and Immunity. 2003; 71(1): 267-70. 23. Gustavo CR and Senanayake N. Neurological manifestations of malaria. Arqneuro- Psiquiat. 1992; 50(1):273-274. 24. Dondorp AM, Fanello CI. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. The Lancet. 2010; 376(9753):1647-1657. 25. Bardaji A, Sigauque B, Sanz S, Maixenchs M, Ordi J, Aponte JJ, et al. Impact of Malaria at the End of Pregnancy on Infant Mortality and Morbidity. Journal of Infectious Disease. 2011; 203(5):691-699. 26. Menendez C, Ordi J, Ismail M.R, Ventura PJ, Aponte JJ, Kahigwa E, et al. The impact of placental malaria on gestational age and birth weight. Journal of Infectious Diseases. 2000; 181(5):1740-1745. 27. Kalilani L, Mofolo I, Chaponda M, Rogerson SJ, Meshnick SR. The effect of timing and frequency of Plasmodium falciparum infection during pregnancy on the risk of low birth weight and maternal anemia. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2010; 104(6): 416-422. 28. Huynh BT, Fievet N, Gbaguidi G, Dechavanne S, Borgella S, Guezo-Mevo B et al. Influence of the timing of malaria infection during pregnancy on birth weight and on maternal anemia in Benin. American Journal of Tropical Medicine and Hygiene. 2011; 85(2): 214- 220. 29. Valea L, Tinto H, Drabo MK, Huybregts L, Sorgho H, Ouedraogo JB, et al. An analysis of timing and frequency of malaria infection during pregnancy in relation to the risk of low birth weight, anaemia and perinatal mortality in Burkina Faso. Malaria Journal. 2012; 11(71). doi:10.1186/1475-2875-11-71. 30. Conroy A. Biomarkers of Severe Malaria: Complement Activation and Dysregulated Angiogenesis in Placenta Malarial and Cerebral Malaria. PhD thesis.2012.http://hdl.handle.net/1807/32064. 31. Prudencio M, Rodriguez A, Mota MM. Silence path to thousands of merozoites: the Plasmodium liver stage. Nature Reviews Microbiology. 2006; 4(11): 849-856. 32. Pierre AB, Safeukui I, Deplaine G, Brousse V, Prendki V, Thellier M. The pathogenesis of Plasmodium falciparum malaria in humans: insights from splenic physiology. Blood. 2011; 117(2): 381-392. 33. Faiz MA, Rahmani MR, Hossain MA, Rashid HA. Cerebral Malaria- A Study of 104 Cases. Bangladesh. Bangladesh Medical Research Council Bulletin.1998; 24(2): 35-42. 34. Ogino S, Redline RW. Villous capillairy lesions of the placenta: distinctions between chorangioma, chorangiomatosis and chorangiosis, Human Pathology. 2000; 31(8): 945-954.35. McGready RBB, Davison K, Stepniewska T, Cho H, Shee A, Brockman A, et al. The effects of Plasmodium falciparum and P. vivax infections on placental histopathology in an area of low malaria transmission. American Journal of Tropical Medicine and Hygiene. 2004; 70(4): 398-407. 36. Chen C. Development of antimalarial drugs and their application in China: a historical review. Infectious Diseases of Poverty. 2014; 3(9): 1-10. 37. Dondorp AMM, Nyanoti M, Kager PA, MithwaniS,Vreeken J, Marsh K.The role of reduced red cell deformability in the pathogenesis of severe falciparum malaria and its restoration by blood transfusion. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2002; 96(3): 282-286. 38. Anand AC and Puri P. Jaundice in malaria. Journal of Gastroenterology and Hepatology. 2005; 20(9):1322-1332. 39. Shivakumar B.G, and Sekhar S.P. Renal and hepatic derangements in malaria with clinical outcome. Indian Journal of Basic and Applied Medical Research. 2015; 4(2): 528-534. 40. Ashraf M and Fahad SA. Study Correlating the Derangement of Liver Function Tests in Vivax and Falciparum Malaria. IOSR Journal of Dental and Medical Sciences. 2014; 13(8): 81-84. 41. Kochar DK, Singh P, Agarwal P, Kochar S.K, Pokharna R, SareenP.K.Malarial hepatitis. Journal Association of Physicians of India. 2003; 51: 1069-1072. 42. Asante D, Ameyaw OA, Effah-Yeboah E, Gyamenah AP, Djabanor J. Hepatoprotective effect of ethanolic leaf extracts of Abrusprecatoriusin Plasmodium bergheiinfected imprinting control region (ICR) mice; A histopathological perspective. International Journal of Biological and Pharmaceutical Research. 2015; 6(10): 814-821. 43. Bhalla A, Suri V, Singh V. Malarial hepatopathy. Journal of Postgraduate Medicine. 2006; 52: 315-320. 44. Gupta BK, Sharma K, Nayak KC, Agrawal TD, Binani A. A case series of splenic infarction during acute malaria in northwest Rajasthan, India. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2010; 104(1):81-83. 45. Kim EM, Cho HJ, Cho CR, Kwak YG, Kim MY, Abdominal computed tomography findings of malaria infection with Plasmodium vivax. American Journal of Tropical Medicine and Hygiene. 2010; 83(6): 1202-1205. 46. Siqueira MA, Magalha BML, Melo GC, Ferrer M, Castillo P, Martin-Jaular L, et al. Spleen Rupture in a Case of Untreated Plasmodium vivax Infection. PLoS Neglected Tropical Diseases. 2012; 6(12):1934-1939. 47. Taylor SM, Cerami C, Fairhurst SM. Hemoglobinopathies: Slicing the Gordian KnotofPlasmodium falciparum Malaria Pathogenesis. Plos Pathogens. 2013; 9(5): e1003327. doi:10.1371/journal.ppat.1003327. 48. Mokashi AJ, Shirahatti RG, Prabhu SK, Va-gholkar K.R. Pathological rupture of malarial spleen. Journal of Postgraduate Medicine. 1992; 38(3): 141-142. 49. Rizwan F, Qamarunisa H, Memon A. Prevalence of anemia in pregnant women and its effects on maternal and fetal morbidity and mortality. Pakistan Journal Medical Sciences. 2010; 26 (1): 92-95. 50. Boampong JN, Karikari AA, Ameyaw OE. In vivoantiplasmodial and in vitro antioxidant properties of stem bark extracts of Haematostaphisbarteri. Asian Pacific Journal Tropical Biomedicine. 2015; 5(6): 446-450. 51. Oue´draogo S, Koura GK, Bodeau-Livinec F, Accrombessi MMK. Maternal Anemia in Pregnancy: Assessing the Effect of Routine Preventive Measures in a Malaria-Endemic Area. American Journal Tropical Medicine Hygiene. 2013; 88(2): 292-300. 52. Zuccala ES, Baum J. Cytoskeletal and membrane remodeling during malaria parasite invasion of the human erythrocyte. British Journal of Haematology. 2011; 154(6): 680- 689. 53. Gysin J, Pouvelle B, Le Tonqueze M, EdelmanL, Boffa M.C. Chondroitin sulfate of thrombomodulin is an adhesion receptor for Plasmodium falciparum-infected erythrocytes. Molecular and Biochemical Parasitology.1997; 88(1): 267-271. 54. Dorman EK, Shulman CE. Impaired uteroplacental blood flow in pregnancies complicated by falciparum malaria. Ultrasound Obstetric Gynecology. 2002; 19(2): 165- 670. 55. De Beaudrap P, Turyakira E, White LJ, Nabasumba C, Tumwebaze B, Muehlenbachs A, et al. Impact of malaria during pregnancy on pregnancy outcomes in a Ugandan prospective cohort with intensive malaria screening and prompt treatment. Malaria Journal. 2013; 12(139): 10-1186. 56. Nweneka CV, Doherty CP, Cox S, Prentice A. Iron delocalization in the pathogenesis of malarial anaemia. Transaction of the Royal Society of Tropical Medicine and Hygiene; 2010; 104(3): 175-84. 57. Skorokhod OA, Caione L, Marrocco T, Migliardi G, Barrera V, Arese P et al. Inhibition of erythropoiesis in malaria anemia: role of hemozoin and hemozoin-generated 4- hydroxynonenal. Blood. 2010; 116: 4328-4337. 58. Cowman FA, Drew F, Jake B. The cellular and molecular basis for malaria parasite invasion of the human red blood cell. Journal of Cell Biology. 2012; 198(6): 961-971. 59. Musumeci G, Castrogiovanni P, Trovato FM, Parenti R, Szychlinska MA, Imbesi R. Pregnancy, embryo-fetal development and nutrition: physiology around fetal programming. Journal of Histology and Histopathology. 2015; 2(1):1-6.60. McDevitt MM, Xie J, Shanmugasundaram G, Griffith J, Liu A, McDonald C. et al. A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anaemia. Journal of Experimental Medicine. 2006; 203(5): 1185-1196. 61. Ghosh K, Ghosh K. Pathogenesis of anemia in malaria: a concise review. Parasitology Research. 2007; 101(6): 1463-1469. 62. Pradhan P. Malarial anaemia and nitric oxide induced megaloblastic anaemia: a review on the causes of malarial anaemia. Journal of Vector Borne Disease. 2009; 46(2): 100- 108.63. Harvey RA, Champe PC. Pharmacology, 4th Edition, 2009, Lippincott Williams and Wilkins,Florida. Pp 501-503. 64. Hviid L. The immuno-epidemiology of pregnancy-associated Plasmodium falciparum malaria: a variant surface antigen-specific perspective. Parasite Immunology. 2004;26(12): 477-486. 65. Aribodor DN, Nwaorgu OC, Eneanya CI, Okoli I, Pukkila-Worley R, Etaga HO, Association of low birth weight and placental malarial infection in Nigeria. Journal of Infections in Developing Countries. 2009; 3(8): 620-623. 66. Berendt AR, Ferguson DJ, Newbold CI, Sequestration in Plasmodium falciparum malaria: sticky cells and sticky problems. Parasitology Today. 1990; 6(8): 247-254.67. Nosten F, Rogerson SJ, Beeson JG, McGready R, Mutabingwa TK, Brabin B. Malaria in pregnancy and the endemicity spectrum: what can we learn? Trends in Parasitology. 2004; 20(9): 425-432. 68. Rowe JA, Kyes SA. The role of Plasmodium falciparum var genes in malaria in pregnancy. Molecular Microbiology. 2004; 53(4): 1011-1019. 69. Neres R, Marinho CRF, Gonçalves LA, Catarino MB, Penha-Gonçalves C. Pregnancy outcome and placenta pathology in Plasmodium bergheiANKA infected mice reproduce the pathogenesis of severe malaria in pregnant women. PLoS One. 2008; 3(2):e1608. 70. Rodrigues-Duarte L, de Moraes LV, Barboza R, Marinho CRF, Franke-Fayard B, Janse CJ et al. Distinct placental malaria pathology caused by different Plasmodium bergheilines that fail to induce cerebral malaria in the C57BL/6 mouse. Malaria Journal. 2012;11(231): 1-9.71. Redline RW. Elevated circulating fetal nucleated red blood cells and placental pathology in term infants who develop cerebral palsy. Human Pathology. 2008; 39(9): 1378-1384.72. Brabin BJ. Congenital malaria: a recurrent problem. Annals of Tropical Paediatrics. 2007; 27(2): 95-98. 73. Khunrae P, Dahlbäck M, Nielsen MA, Andersen G, Ditlev SB, Resende M, et al. Fulllength recombinant Plasmodium falciparum VAR2CSA binds specifically to CSPG and induces potent parasite adhesion-blocking antibodies. Journal of Molecular Biology. 2010; 397:826-834. 74. Clausen TM, Christoffersen S, Dahlbäck M, Langkilde AE, Jensen KE, Resende MA. et al. Structural and functional insight into how the Plasmodium falciparum VAR2CSAprotein mediates binding to chondroitin sulfate A in placental malaria. J. Biol. Chem.2012; 287: 23332- 23345.75. Beaudet JM, Mansur L, Joo EJ, Kamhi E. Yang B, Clausen TM, et al. Characterization of human placental glycosaminoglycans and regional binding to VAR2CSA in malaria infected erythrocytes. Glycoconj J. 2014; 31:109-116 76. Gnidehou S, Doritchamou J, Arango EM, Cabrera A, Arroyo MI, Kain KC, et al. Functional Antibodies against VAR2CSA in Non-pregnant Populations from Colombia Exposed to Plasmodium falciparum and Plasmodium vivax. Infect. Immun. 2014; 82(6):2565-2571. 77. Khong YT, Bendon RW, Qureshi F, Redline RW, Gould S, Stallmach T, et al. Chronic deciduitis in the placental basal plate: definition and inter observer reliability. Human Pathology. 2000; 31(3): 292-295. 78. Ohyama M, Itani Y, Yamanaka M, Goto A, Kato K, Ijiri R, et al. Maternal, neonatal, and placental features associated with diffuse chorioamniotichaemosiderosis, with special reference to neonatal morbidity and mortality. Pediatrics. 2004; 113(4): 800-805. 79. Watkinson M, Rushton DI. Plasmodial pigmentation of placenta and outcome of pregnancy in West African mothers. British Medical Journal.1983; 287(6387): 251-254. 80. Redline RW, Faye-Petersen O, Heller D, Qureshi F, Savell V, Vogler C. The Society for Pediatric Pathology, Perinatal Section, Amniotic Fluid Infection Nosology Committee. Amniotic infection syndrome: nosology and reproducibility of placental reaction patterns. Pediatric Developmental Pathology. 2003; 6(5): 435-448. 81. Redline RW, Boyd T, Campbell V, Hyde S, Kaplan C, Khong TY, et al. The Society for Pediatric Pathology, Perinatal Section, Maternal Vascular Underperfusion Nosology Committee. Maternal vascular underperfusion: nosology and reproducibility of placental reaction patterns. Pediatric Developmental Pathology. 2004; 7(3): 237-249. 82. Conroy A, Serghides L, Finney C, Owino SO, Kumar S, Gowda DC, et al. C5a enhances dysregulated inflammatory and angiogenic responses to malaria in vitro: potential implications for placental malaria. PLoS One. 2009; 4(3):e4953. 83. Persson KE, McCallum FJ, Reiling L, Lister NA, Stubbs J, Cowman AF, et al. Variation in use of erythrocyte invasion pathways by Plasmodium falciparum mediates evasion of human inhibitory antibodies. Journal of Clinical Investigation. 2008; 118(1): 342-351. 84. Fox H, Sebire NJ. Pathology of the Placenta-Major Problems in Pathology. 3rd Edition, Saunders-Elsevier, 2008. 85. Redline RW, O'Riordan MA. Placental lesions associated with cerebral palsy and neurologic impairment following term birth. Archieves of Pathology and Laboratory Medicine. 2000; 124(12): 1785-1791. 86. Redline RW. Severe fetal placental vascular lesions in term infants with neurologic impairment. Journal of Obstetric Gynecology. 2005; 192(2): 452-457. 87. Roescher AM, Hitzert MM, Timmer A, Verhagen EA, Erwich JJHM, Bos AF. Placental pathology is associated with illness severity in preterm infants in the first twenty-four hours after birth. Early Human Development. 2011; 87(4): 315-319. 88. Steketee RW, Wirima JJ, Hightower AW. The effect of malaria and malaria prevention in pregnancy on offspring birth weight, prematurity and intrauterine growth retardation in rural Malawi. American Journal of Tropical Medicine and Hygiene. 1996; 55(l1): 33-41. 89. D'Alessandro U, Langerock P, Bennet S, Francis N, Cham K, Greenwood BM. The impact of a national bed net program on the outcome of pregnancy in primigravidae in The Gambia. Transaction of the Royal Society of Tropical Medicine and Hygiene.1996; 90: 487-492. 90. Armulik A, Genove G. Pericytes regulate the blood-brain barrier. Nature. 2010; 468(7323): 557-561. 91. Dondorp A, Nosten F. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet. 2005; 366(9487): 717-725. 92. Riganti M, Pongponratn E. Human cerebral malaria in Thailand: a clinico-pathological correlation. Immunology Letters. 1990; 25(1): 199-205. 93. Patankar TF, Karnad DR. Adult Cerebral Malaria: Prognostic Importance of Imaging Findings and Correlation with Postmortem Findings. Radiology. 2002; 224(3): 811-816.94. Daneman R, Zhou L. Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature. 2010; 468(323): 562-566. 95. Brown HC, Chau TT. Blood-brain barrier functions in cerebral malaria and CNS infections in Vietnam. Neurology. 2000; 55(1): 104-111. 96. Brown H, Rogerson S. Blood-brain barrier functions in cerebral malaria in Malawian children. American Journal of Tropical Medicine and Hygiene. 2001; 64(3): 207-213. 97. White VA, Lewallen S. Correlation of retinal haemorrhages with brain haemorrhages in children dying of cerebral malaria in Malawi. Transaction of the Royal Society of Tropical Medicine and Hygiene. 2001; 95(6): 618-621. 98. Rijken MJ, de Wit CM, Mulder EJH, Kiricharoen S, Karunkonkowit N, Paw T, et al. Effect of malaria in pregnancy on fetal cortical brain development: a longitudinal observational study. Malaria Journal. 2012; 11(222):1-6. 99. Lieberman E, Lang J, Richardson DK, Frigoletto FD, Heffner LJ, Cohen C. Intrapartum Maternal Fever and Neonatal Outcome. Pediatrics. 2000; 105(8):8-13. 100. Moretti ME, Bar-Oz B, Fried S, Koren G. Maternal hyperthermia and the risk for neural tube defects in offspring systematic review and meta-analysis. Epidemiology. 2005; 16(2): 216- 219. 101. Medana M, Hien TT. The clinical significance of cerebrospinal fluid levels of kynurenine pathway metabolites and lactate in severe malaria. Journal of Infectious Disease; 2002; 185(5): 650-656. 102. Jamieson DJ, Theiler RN, Rasmussen SA. Emerging Infections and Pregnancy. Emerging Infectious Diseases. 2006; 12(11): 1638-1643. 103. Szekeres-Bartho J. Immunological relationship between the mother and the fetus. International Review of Immunology. 2002; 21(6): 471-495. 104. Takem EN, D'Alessandro U. Malaria in pregnancy. Mediterranean Journal of Hematology and Infectious Disease. 2013; 5(1):1-14. 105. Bouyou-Akotet M.K, Adegnika A.A, Agnandji S.T, Ngou-MilamaE, Kombila M, Kremsner PG, Mavoungou E. Cortisol and susceptibility to malaria during pregnancy. Microbes Infection. 2005; 7(11): 1217-1223. 106. De Nys HM, Calvignac-Spencer S, Boesch C, Dorny P, Wittig RM, Mundry R, et al. Malaria parasite detection increases during pregnancy in wild chimpanzees. Malaria Journal. 2014; 13(1): 413- 419. 107. Maestre A, Carmona-Fonseca J. Immune responses during gestational malaria: a review of the current knowledge and future trend of research. Journal of Infection in Developing Countries.2014; 8(4): 391-402. 108. Mor G, Cardenas I. The Immune System in Pregnancy: A Unique Complexity. American Journal of Reproductive Immunology. 2010:63(6): 425-433. 109. Miles D, van der Sande M, Crozier S, Ojuola O, Palmero M, Sanneh M, et al. Effect of Antenatal and Postnatal environment on CD4 T-cell Responses to BCG in healthy Gambian infants. Clinical Vaccine Immunology. 2008; 15(6): 995-1002.